| Bioactivity | TUG-905 is a potent GPR40 agonist with an pEC50 value of 7.03. TUG-905 increases hypothalamic cell proliferation and survival. TUG-905 reduces body mass and increases the POMC mRNA expression[1][2]. |
| Target | pEC50: 7.03 (GPR40) |
| Invitro | TUG-905 (10 µM;7、13 天) 促进细胞增殖和增加神经母细胞标记物 DCX mRNA 水平[2]。TUG-905 (10 µM;2、4、24 小时) 增加 Neuro2a (鼠神经母细胞瘤) 细胞中的 GPR40、BDNF 基因表达[2]。 Western Blot Analysis[2] Cell Line: |
| In Vivo | TUG-905 (2.0 μL,1.0 mM;i.c.v.;每天两次,持续 6 天) 可降低体重并表现出减少热量摄入的趋势[1]。 Animal Model: |
| Name | TUG-905 |
| CAS | 1390641-90-3 |
| Formula | C27H30FNO5S |
| Molar Mass | 499.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dragano NRV, et al. Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation. J Neuroinflammation. 2017 Apr 26;14(1):91. [2]. Engel DF, et al. Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms. Sci Rep. 2020 Jul 6;10(1):11047. |